Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or for the provision of patient care. This tool is intended for research use only (RUO). Alimentiv is developing digital image analysis tools to aid pathologists in scoring patient biopsies and […]... read more

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality rates and limited treatment options. Study Goal: Evaluate the safety and pharmacokinetics of SZN-043, a novel therapeutic candidate designed by Surrozen, in participants with severe alcohol-associated hepatitis. Leveraging Alimentiv’s Expertise […]... read more

With A Proven Quality By Design Framework Applying our Quality By Design framework in clinical trials saves time, money, and resources. These are crucial, precious, and practical factors to consider before starting a study. An ingrained Quality By Design framework achieves this by:... read more

Alimentiv, a full-service GI CRO and pioneer in IBD medical imaging solutions since 1986, is excited to announce the expansion of its partnership with Satisfai Health, a leader in AI medical solutions for GI diseases. ... read more

London, Ontario, Canada, October 11, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce four poster presentations at the United European Gastroenterology (UEG) conference taking place October 12-15, 2024, at the Reed Messe Wien Exhibition Congress Center, in Vienna, Austria. Alimentiv is the leading contract research organization (CRO) for gastroenterology (GI) clinical trial management and […]... read more

If you’ve missed some of our lecture presentations and poster sessions, reach out for more information.... read more

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease Week (DDW) Meetings and Trade Show taking place May 18-21, 2024 at the Walter E. Washington Convention Center in Washington, D.C. Alimentiv is a globally recognized leader in outcome measures […]... read more

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled opportunities for collaboration, education, and professional development in the field of gastrointestinal medicine.  Join us as we navigate the path toward groundbreaking medical advancements in GI health. Top […]... read more

Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase 4 prospective open-label study of a triple-combination therapy in participants with moderate to severe Crohn’s disease did not have comparison arms of participants treated with placebo or the associated monotherapies, […]... read more

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. This announcement follows a comprehensive international CEO search conducted by the Board of Directors.  Pierre brings a wealth of experience, with over 25 years of executive expertise managing […]... read more

We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources. Each of these sources has utilized its own methodologies and datasets to represent market conditions. By collecting the information from all these sources, we aimed to present readers with an […]... read more

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH) clinical trials. This collaboration will enable clinical trial sponsors to quantify the […]... read more

London, Ontario, Canada, October 13, 2023, Alimentiv Inc. (“Alimentiv”), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of new scientific advisors to its scientific advisory board.  The advisors are internationally recognized experts in designing and conducting clinical research in Inflammatory Bowel Disease.  Their contributions to the field have […]... read more

Due to Contract Research Organizations’ (CROs) significant impact on drug development and healthcare advancements, understanding the size and future growth of the CRO Market is vital. It is particularly essential now, as the demand for cost-effective and specialized research services rises. To help present a robust view of the CRO market, we have collated data […]... read more

London, Canada and Vancouver, Canada – Alimentiv, a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries, and Satisfai Health, a Vancouver-based software company focused on the application of artificial intelligence to gastrointestinal disease assessment, are announcing the commercial availability of […]... read more

The lack of diversity in clinical trial populations has been a longstanding issue in the medical and research communities. While some researchers and advocates have been raising this concern for many years, in today’s rapidly evolving landscape of medical research and healthcare, the impact of diversity on clinical trials has garnered increasing attention. In this […]... read more

Clinical trial designs can be classified into several categories, each with its unique characteristics and objectives. This guide provides a broad look at the many clinical trial designs available. It suggests the most suitable designs for specific research objectives and highlights their key features, benefits, and considerations.  Different Types of Clinical Trial Designs – Part […]... read more

Designing a biomarker plan for a clinical trial can be challenging due to the plethora of assays and advancing technologies that are now readily available. A well-defined biomarker plan sets the stage for success as it is designed to align the translational objectives with clinical study constraints. In this blog, we discuss factors that go […]... read more

If adaptive designs can bring strong advantages to clinical trials, then why does their adoption remain low?  Clinical trials typically follow a fixed design, where the protocol is established before the study begins and is planned to remain unchanged throughout the trial. Adaptive designs, on the other hand, are planned to allow for modifications based […]... read more

In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often used interchangeably. However, despite their similarities, they do have distinct differences in their focus and applications. Main Difference Statistics encompasses methods of collecting, organizing, analyzing, presenting, and interpreting data to […]... read more

London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the recognized leader for statistical advisory and analysis services in clinical research through a Statistics Centre of Excellence (SCoE) and a robust statistical and analytical workforce. In March 2021, Alimentiv Health […]... read more

Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how they can be optimized for maximum therapeutic benefit. They focus on a drug’s effectiveness and safety by how the body absorbs, distributes, metabolizes and removes that drug. While both concepts […]... read more

The randomized controlled clinical trial (RCT) with a fixed design has been a gold standard for evaluating drug safety and efficacy since its debut. However, for traditional fixed-design RCTs, one drawback is that they may fail to meet the need for flexibility and adaptivity in modern drug development. For instance, sample sizes cannot be adjusted for […]... read more

Continuing with our celebration during Women’s History Month and for International Women’s day, we are proud to profile two more of the incredible women that work at Alimentiv. Today, we are recognizing Heather Gallagher, Director Project Management, and Stephanie Davy, Manager, Human Resources. Heather Gallagher, Director, Project Management With Alimentiv for 5 years Which mentors […]... read more

On International Women’s Day 2023, in keeping with this year’s theme of “Embrace Equity”, Alimentiv continues to celebrate the achievements of women, their courage and determination to take action for equality and raise awareness against bias. We believe in empowering women, so in honour of IWD 2023, we are proud to profile a few of […]... read more

At Alimentiv, we place a high priority on educating our audience and clients about clinical statistical analysis and trial design. As such, we decided it was time to create a reference guide that could serve as a glossary of clinical study design & statistical analysis terms. From sample size to regression and everything in between, there […]... read more

London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH) drug development programs forward faster and more efficiently. NASH is a growing global epidemic with no approved treatments. There are over 100 drugs in clinical development (Fraile et al., 2021). […]... read more

The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network. London, Ontario, Canada, 5 October 2022 – Alimentiv Inc. (“Alimentiv”), Satisfai Health, Inc (“Satisfai”), and Virgo Surgical Video Solutions, Inc. (“Virgo”) today announced a strategic partnership to revolutionize central reading, data capture, decision […]... read more

San Diego, CA, USA, Release: September 15, 2022 – AcelaBio (US) Inc., a contract research organization delivering histopathology and precision medicine laboratory services for global clinical trials, achieved its accreditation by the College of American Pathologists (CAP). CAP accreditation indicates that the laboratory meets stringent requirements of quality, accuracy, and consistency of test results to […]... read more

London, ON, CANADA, Release: August 18, 2022 Alimentiv Health Trust is pleased to announce the appointment of Dr. Amara Siva, Mr. John Fox and Mr. Paul Rothwell to the Alimentiv Holdings Board of Directors.  “We are pleased to welcome Amara, John and Paul to the Alimentiv Holdings Board”, said Jeff Smith, CEO Alimentiv Inc. and Director […]... read more

At Alimentiv, our employees come first. We engage inspired and talented individuals who are motivated by our mission and vision, and we continue to learn more about our employees and their unique and niche backgrounds that make up the diverse workforce behind our clinical trial services. Today, we are highlighting one of our employees, Jill Klein, Senior Database Programmer in Data Sciences. We asked Jill some questions and to take us through a day in her role!... read more

Take your clinical trial design from good to great. Poor trial design or planning is the main cause of issues and errors occurring in clinical trials. No amount of statistical methods can rescue poor trial design. Study start-up is a stressful time. Investors, executives, and trialists push to reach the first milestone of recruiting the […]... read more

What are they? What are bioequivalence studies (BE)? BE studies are a special type of studies designed to compare (i.e., the amount of drug that enters systemic circulation) two products that are using the same active ingredient or molecule and to verify how similar they are to each other. Once a pharmaceutical company develops a […]... read more

London, ON, CANADA, Release: January 27, 2022 The International Bowel Ultrasound (IBUS) Group e.V. and Alimentiv Inc. announced today a partnership to offer intestinal ultrasound (IUS) central reading services in clinical trials of adults and children with inflammatory bowel disease (IBD). Owing to its cost-effectiveness, tolerability and repeatability, IUS has played an increasing role as... read more

Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Judi Hall, Vice President, Clinical Research for Alimentiv. Judi took some time to discuss her growth and development within the company, motivation, and inspiration... read more

London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real-time data and secure access to all clinical documentation throughout the clinical trial lifecycle. As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve... read more

Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Arti Ramji, Senior Manager, Human Resources & Engagement for Alimentiv. Arti took some time to discuss her growth and development within the company, motivation,... read more

As a research pharma or biotech, you face a complex and regulatory-heavy environment. New developing products make competition fierce, while a trend in regulatory control of protocols and funding has created myriad challenges for building a case to maintain funding levels year over year. To keep time and funds spent during the clinical phases reduced […]... read more

No one wants a clinical trial to go into rescue, but it happens. And often, it’s completely avoidable. Here are six pieces of advice to help you keep your trial on track. Number 1: Pay Attention to the Obvious To save your trial from rescue, you need to recognize the signs that it may be failing. […]... read more

Alimentiv is pleased to announce that Mike Reffeitt joined Alimentiv Inc. as the new Chief Financial Officer, effective Monday, May 3, 2021. Mike will be working alongside the executive team to drive the business and strategy of the Alimentiv group of companies forward and support our corporate operations teams including IT, legal, quality, facilities, and... read more

London, ON, CANADA, Release: April 14, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), and McDougall Scientific Ltd., a niche CRO, announced today the launch of AcelaBio, a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for... read more

An electronic master file or eTMF is a Trial Master File in electronic or digital format. It is a way of digitally capturing, managing, sharing and storing those essential documents and content from a clinical trial. CONTENTS To understand further, let’s first describe what a Trial Master File or TMF is. Every organization, typically a pharmaceutical […]... read more

International Women’s Day 2021 is on Monday, March 8th. Alimentiv is proud to celebrate this, honour the achievements of women across the globe, and continues to foster a culture where all employees and prospective candidates receive equal opportunities.... read more

London, ON, CANADA, Release: March 2, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), announced today the acquisition of McDougall Scientific Ltd. a niche CRO specializing in statistical analysis, top-tier data management, reporting, and clinical trial design. The acquisition... read more

A patient reported outcome measure, or PRO, may be defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.” These measures are widely used to study chronic diseases and are considered by regulatory agencies such... read more

Our corporate team "IBD Eliminators" are featured as the Corporate Team for Gutsy Walk! Including dedicated employees of Alimentiv Clinical Trials and supportive friends and family, our team has participated since 2017.... read more

Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO).... read more

Alimentiv’s Response to the COVID-19 pandemic and how we are still working to provide safe, quality service to our partners, sponsors, vendors and investigators.... read more